Actavis in Middle East/Africa/Asia-Pacific
Actavis has been strengthening its platform in the Middle East/Africa/Asia-Pacific region through strategic acquisitions and partnerships. The Company maintains modern, state-of-the-art development and manufacturing facilities throughout Asia-Pacific, including China, India, Indonesia and Singapore. These facilities produce a range of medicines in various formulations, including tablet, soft gel capsule, hard capsule, oral solution, dry suspension, ointments and liniments.
Actavis’ Asia-Pacific commercial offices are located in: Indonesia, Singapore, Australia, Hong Kong, Japan, Kazakhstan, Mongolia, United Arab Emirates, Vietnam and South Africa.